The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-{4-[6-Amino-5-(4-chlorophenyl)pyridin-3-yl]phenyl}propanoic acid ID: ALA4793121
PubChem CID: 162671261
Max Phase: Preclinical
Molecular Formula: C20H17ClN2O2
Molecular Weight: 352.82
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncc(-c2ccc(CCC(=O)O)cc2)cc1-c1ccc(Cl)cc1
Standard InChI: InChI=1S/C20H17ClN2O2/c21-17-8-6-15(7-9-17)18-11-16(12-23-20(18)22)14-4-1-13(2-5-14)3-10-19(24)25/h1-2,4-9,11-12H,3,10H2,(H2,22,23)(H,24,25)
Standard InChI Key: CPYBMXWQSDLGOO-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
27.8468 -4.4194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6804 -1.9686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6793 -2.7882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3873 -3.1972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0970 -2.7877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0941 -1.9651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3855 -1.5598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8018 -3.1944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8017 -4.0127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5093 -4.4201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2173 -4.0104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2134 -3.1890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5053 -2.7853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8003 -1.5538 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9731 -3.1965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2654 -2.7856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5579 -3.1930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5568 -4.0111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2692 -4.4201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9738 -4.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9262 -4.4169 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.1398 -4.0096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4314 -4.4170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7244 -4.0073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.4301 -5.2342 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
5 8 1 0
6 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
3 15 1 0
11 21 1 0
18 1 1 0
1 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 352.82Molecular Weight (Monoisotopic): 352.0979AlogP: 4.67#Rotatable Bonds: 5Polar Surface Area: 76.21Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.66CX Basic pKa: 7.01CX LogP: 2.87CX LogD: 2.35Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.70Np Likeness Score: -0.31
References 1. Dow RL,Ammirati M,Bagley SW,Bhattacharya SK,Buckbinder L,Cortes C,El-Kattan AF,Ford K,Freeman GB,Guimarães CRW,Liu S,Niosi M,Skoura A,Tess D. (2018) 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety., 61 (7): [PMID:29570292 ] [10.1021/acs.jmedchem.8b00152 ]